FAN1 nuclease inhibitor Therapy(Harness Therapeutics)

N/A

Report date: 2024/01/29 17:30:17

Base Information

Drug NameFAN1 nuclease inhibitor Therapy(Harness Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFANCD2 And FANCI Associated Nuclease 1 inhibitors
TargetsFANCD2 And FANCI Associated Nuclease 1
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarness Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHarness Therapeutics
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A